438 related articles for article (PubMed ID: 16580667)
81. Androgen receptor gene expression in leucocytes is hormonally regulated: implications for gender differences in disease pathogenesis.
Sader MA; McGrath KC; Hill MD; Bradstock KF; Jimenez M; Handelsman DJ; Celermajer DS; Death AK
Clin Endocrinol (Oxf); 2005 Jan; 62(1):56-63. PubMed ID: 15638871
[TBL] [Abstract][Full Text] [Related]
82. Androgen receptor isoforms in human prostatic cancer tissue and LNCaP cell line.
Xia SJ; Tang XD; Ma QZ
Asian J Androl; 2001 Sep; 3(3):223-5. PubMed ID: 11561194
[TBL] [Abstract][Full Text] [Related]
83. Decreased androgen receptor levels and receptor function in breast cancer contribute to the failure of response to medroxyprogesterone acetate.
Buchanan G; Birrell SN; Peters AA; Bianco-Miotto T; Ramsay K; Cops EJ; Yang M; Harris JM; Simila HA; Moore NL; Bentel JM; Ricciardelli C; Horsfall DJ; Butler LM; Tilley WD
Cancer Res; 2005 Sep; 65(18):8487-96. PubMed ID: 16166329
[TBL] [Abstract][Full Text] [Related]
84. Theaflavin-3,3'-digallate and penta-O-galloyl-beta-D-glucose inhibit rat liver microsomal 5alpha-reductase activity and the expression of androgen receptor in LNCaP prostate cancer cells.
Lee HH; Ho CT; Lin JK
Carcinogenesis; 2004 Jul; 25(7):1109-18. PubMed ID: 14963012
[TBL] [Abstract][Full Text] [Related]
85. Dihydrotestosterone as a selective cellular/nuclear localization vector for anti-gene peptide nucleic acid in prostatic carcinoma cells.
Boffa LC; Scarfi S; Mariani MR; Damonte G; Allfrey VG; Benatti U; Morris PL
Cancer Res; 2000 Apr; 60(8):2258-62. PubMed ID: 10786693
[TBL] [Abstract][Full Text] [Related]
86. Cellular repair of oxidatively induced DNA base lesions is defective in prostate cancer cell lines, PC-3 and DU-145.
Trzeciak AR; Nyaga SG; Jaruga P; Lohani A; Dizdaroglu M; Evans MK
Carcinogenesis; 2004 Aug; 25(8):1359-70. PubMed ID: 15044326
[TBL] [Abstract][Full Text] [Related]
87. Androgen receptor and androgen-dependent gene expression in lung.
Mikkonen L; Pihlajamaa P; Sahu B; Zhang FP; Jänne OA
Mol Cell Endocrinol; 2010 Apr; 317(1-2):14-24. PubMed ID: 20035825
[TBL] [Abstract][Full Text] [Related]
88. [Significance of both nuclear and cytosol androgen receptor (AR) in assessment of AR status in prostate carcinoma and hepatocellular carcinoma].
Lu HP; Gao JH
Ai Zheng; 2003 Feb; 22(2):168-70. PubMed ID: 12600293
[TBL] [Abstract][Full Text] [Related]
89. Polymorphisms of human androgen receptor (hAR) gene in prostate cancer cell lines PC-EW and PC-OR.
Engehausen DG; Krause FS; Fleischmann J; Akcetin Z; Schrott KM; Endele S
Anticancer Res; 2005; 25(3A):1611-4. PubMed ID: 16033069
[TBL] [Abstract][Full Text] [Related]
90. Cell-cell adhesion molecules and signaling intermediates and their role in the invasive potential of prostate cancer cells.
Davies G; Jiang WG; Mason MD
J Urol; 2000 Mar; 163(3):985-92. PubMed ID: 10688036
[TBL] [Abstract][Full Text] [Related]
91. Expression of melanocortin receptors in human prostate cancer cell lines: MC2R activation by ACTH increases prostate cancer cell proliferation.
Hafiz S; Dennis JC; Schwartz D; Judd R; Tao YX; Khazal K; Akingbemi B; Mo XL; Abdel-Mageed AB; Morrison E; Mansour M
Int J Oncol; 2012 Oct; 41(4):1373-80. PubMed ID: 22842514
[TBL] [Abstract][Full Text] [Related]
92. Inhibition of human androgen-independent PC-3 and DU-145 prostate cancers by antagonists of bombesin and growth hormone releasing hormone is linked to PKC, MAPK and c-jun intracellular signalling.
Stangelberger A; Schally AV; Varga JL; Zarandi M; Cai RZ; Baker B; Hammann BD; Armatis P; Kanashiro CA
Eur J Cancer; 2005 Nov; 41(17):2735-44. PubMed ID: 16291086
[TBL] [Abstract][Full Text] [Related]
93. Prostate tumor CXC-chemokine profile correlates with cell adhesion to endothelium and extracellular matrix.
Engl T; Relja B; Blumenberg C; Müller I; Ringel EM; Beecken WD; Jonas D; Blaheta RA
Life Sci; 2006 Mar; 78(16):1784-93. PubMed ID: 16263140
[TBL] [Abstract][Full Text] [Related]
94. Calcium regulation of androgen receptor expression in the human prostate cancer cell line LNCaP.
Gong Y; Blok LJ; Perry JE; Lindzey JK; Tindall DJ
Endocrinology; 1995 May; 136(5):2172-8. PubMed ID: 7720667
[TBL] [Abstract][Full Text] [Related]
95. Molecular cloning and characterization of STAMP2, an androgen-regulated six transmembrane protein that is overexpressed in prostate cancer.
Korkmaz CG; Korkmaz KS; Kurys P; Elbi C; Wang L; Klokk TI; Hammarstrom C; Troen G; Svindland A; Hager GL; Saatcioglu F
Oncogene; 2005 Jul; 24(31):4934-45. PubMed ID: 15897894
[TBL] [Abstract][Full Text] [Related]
96. [Expression and clinical significance of antiapoptosis gene XIAP in prostate cancer].
Liu J; Li M; Xia S
Zhonghua Nan Ke Xue; 2004 Nov; 10(11):832-5. PubMed ID: 15595685
[TBL] [Abstract][Full Text] [Related]
97. Androgen receptor (AR) expression in prostate cancer and progression of the tumor: Lessons from cell lines, animal models and human specimens.
Tamburrino L; Salvianti F; Marchiani S; Pinzani P; Nesi G; Serni S; Forti G; Baldi E
Steroids; 2012 Aug; 77(10):996-1001. PubMed ID: 22289337
[TBL] [Abstract][Full Text] [Related]
98. Expression of human prostatic acid phosphatase correlates with androgen-stimulated cell proliferation in prostate cancer cell lines.
Lin MF; Meng TC; Rao PS; Chang C; Schonthal AH; Lin FF
J Biol Chem; 1998 Mar; 273(10):5939-47. PubMed ID: 9488733
[TBL] [Abstract][Full Text] [Related]
99. Antigenic expression of human metastatic prostate cancer cell lines for in vitro multiple-targeted alpha-therapy with 213Bi-conjugates.
Li Y; Abbas Rizvi SM; Blair nee Brown JM; Cozzi PJ; Qu CF; Ow KT; Tam PN; Perkins AC; Russell PJ; Allen BJ
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):896-908. PubMed ID: 15465208
[TBL] [Abstract][Full Text] [Related]
100. Testosterone and 5 alpha-dihydrotestosterone inhibit in vitro growth of human breast cancer cell lines.
Ortmann J; Prifti S; Bohlmann MK; Rehberger-Schneider S; Strowitzki T; Rabe T
Gynecol Endocrinol; 2002 Apr; 16(2):113-20. PubMed ID: 12012621
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
